Keyphrases
Older Women
100%
Prognostic Biomarker
100%
Platinum-based
100%
Antineoplastic Drugs
100%
Serous Adenocarcinoma
100%
High-grade Serous
100%
Ankyrin Repeat
100%
PH Domain
100%
High-grade Serous Carcinoma
50%
Older Patients
33%
Ovarian Cancer Patients
33%
Platinum-based Treatment
33%
Immunohistochemistry
16%
Intensive Care Medicine
16%
Regression Analysis
16%
Clinical Trials
16%
Protein Expression
16%
Low Expression
16%
Altered Expression
16%
Immunohistochemical Staining
16%
Independent Prognostic Factor
16%
Patient Outcomes
16%
Potential Biomarkers
16%
Negative Predictive Value
16%
Early Progression
16%
Gene Expression Profiling
16%
Biological Factors
16%
Tumor Samples
16%
Response Prediction
16%
Validation Cohort
16%
Gene Expression Array
16%
Transcriptome Profile
16%
Retrospective Cohort
16%
Early-late
16%
Late Progression
16%
Medicine and Dentistry
Biological Marker
100%
Adenocarcinoma
100%
Pleckstrin Homology Domain
100%
Platinum-Based Antineoplastic
100%
Ankyrin
100%
Serous Carcinoma
50%
Ovarian Cancer
33%
Immunohistochemistry
33%
Gene Expression
16%
Neoplasm
16%
Clinical Trial
16%
Protein Expression
16%
Prognostic Factor
16%
Gene Expression Profiling
16%
Biological Factor
16%
Expression Array
16%
Transcriptomics
16%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Adenocarcinoma
100%
Anticarcinogen
100%
Ankyrin
100%
Carcinoma
50%
Ovary Cancer
33%
Neoplasm
16%
Clinical Trial
16%
Biological Factor
16%
Expression Array
16%
Biochemistry, Genetics and Molecular Biology
Ankyrin
100%
Pleckstrin Homology Domain
100%
Ankyrin Repeat
100%
Gene Expression
16%
Clinical Trial
16%
Protein Expression
16%
Gene Expression Profiling
16%
Transcriptomics
16%
Immunology and Microbiology
Prognostic Biomarker
100%
Pleckstrin Homology Domain
100%
Gene Expression
16%
Protein Expression
16%
Gene Expression Profiling
16%
Transcriptomics
16%
Biological Factor
16%